Amylyx Pharmaceuticals Inc AMLX

NAS: AMLX | ISIN: US03237H1014   17/05/2024
1,830 USD (0,00%)
(0,00%)   17/05/2024
Grafiek Amylyx Pharmaceuticals Inc Grafiek Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc in het nieuws

8 april 2024 · Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc.(AMLX) Shareholders · Persbericht

5 april 2024 · AMLX Investors Have Opportunity to Lead Amylyx Pharmaceuticals, Inc. Securities Fraud Lawsuit · Persbericht

4 april 2024 · SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx · Persbericht

3 april 2024 · Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights - AMLX · Persbericht

1 april 2024 · Levi & Korsinsky Reminds Amylyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX · Persbericht

30 maart 2024 · AMYLYX PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLX · Persbericht

27 maart 2024 · April 9, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AMLX · Persbericht

21 maart 2024 · SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx · Persbericht

21 maart 2024 · AMLX Investors Have Opportunity to Lead Amylyx Pharmaceuticals, Inc. Securities Fraud Lawsuit · Persbericht

20 maart 2024 · Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX) - April 9, 2024 Deadline to Join - Contact Levi & Korsinsky · Persbericht

Profiel Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals, Inc is een biofarmaceutisch bedrijf met hoofdkantoor in Cambridge, Massachusetts. Amylyx is vooral bekend van AMX0035, een experimentele therapie voor amyotrofische laterale sclerose.

Werknemers: 259

Aandelen Amylyx Pharmaceuticals Inc

Beurswaarde: 124,45 miljoen USD

Effecten: 68,01 miljoen

Winst per aandeel (12 maand):  PLUS

Beta: 1,74

Mijn selecties